EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Endothelial Function and Matrix Metalloproteinase 9 (MMP9) in Women with Polycystic Ovary Syndrome (PCOS)

Vaia Lambadiari, Sotirios Pililis iD, Stamatios Lampsas iD, Aikaterini Kountouri iD, John Thymis iD, Loukia Pliouta iD, Melpomeni Peppa iD, Sophia Kalantaridou, Evangelos Oikonomou iD, Gerasimos Siasos, Ignatios Ikonomidis iD

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms26125488 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Vaia Lambadiari und 10 weiteren Autor:innen. Beteiligte Einrichtung: Diabetes Center, 2nd Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12…. Hauptthemen laut MEDLINE: Polycystic Ovary Syndrome, Matrix Metalloproteinase 9, Endothelium, Vascular. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Polycystic ovary syndrome (PCOS) is a complex endocrine disease. This study investigates the relationship between endothelial function, insulin resistance, and hormonal profiles in women with PCOS. Forty women with PCOS were included: metformin (n = 20), GLP1-RAs (n = 10), and oral contraceptive pills (n = 10). A 75 g oral glucose tolerance test (OGTT) was performed, and the 0, 60, and 120 min insulin, glucose, and endothelial functions were evaluated. The postprandial and fasting state Matsuda Index and HOMA Index were measured. All measurements were performed at baseline and at a 6-month follow-up. At baseline, the percentage change in the Perfused Boundary Region (PBR) was associated with the percentage change in glucose at 120 min of the OGTT (r = 0.42, p < 0.05). The Matsuda Index, Homa Index, and testosterone levels were associated with the PBR (2.91 ± 0.1 μm) at 120 min of the OGTT (r = 0.41, r = 0.38 and r = 0.28, respectively). MMP9 levels were associated with the Matsuda and Homa Index (r = 0.45, p < 0.05 and r = 0.41, p < 0.05, respectively). At the 6-month follow-up, all the participants presented improvements of the Matsuda Index (7 ± 0.31 vs. 9.1 ± 0.2), Homa Index (5.3 ± 0.8 vs. 2.91 ± 0.1), MMP9 (210 ± 30 vs. 178 ± 28 ng/mL), and testosterone levels (44.2 ± 5 vs. 39.1 ± 2 ng/dL) compared to the baseline (p < 0.05 for all the comparisons). Patients who received GLP1-RA agonists presented the greatest improvement in MMP9 levels. Postprandial hyperglycemia, insulin resistance, and testosterone levels are associated with an impaired glycocalyx thickness in women with PCOS.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Polycystic Ovary SyndromeMatrix Metalloproteinase 9Endothelium, VascularHumansFemaleAdultInsulin ResistanceGlucose Tolerance TestBlood GlucoseYoung AdultTestosteroneInsulinMetformin

Stichwörter der Autor:innen

endothelial functioninsulin resistancematrix metalloproteinasespolycystic ovary syndrome

Substanzen

Matrix Metalloproteinase 9Blood GlucoseTestosteroneMMP9 protein, humanInsulinMetformin

Autor:innen und Institutionen

  • Diabetes Center, 2nd Department of Internal Medicine, Attikon University Hospital, Medical School, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • 2nd Department of Ophthalmology, Attikon Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • 2nd Cardiology Department, Attikon University Hospital, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • 3rd Department of Obstetrics and Gynecology, Attikon Hospital, School of Medicine, National and Kapodistrian University of Athens, 12462 Athens, Greece.
  • 3rd Department of Cardiology, Medical School, "Sotiria" Chest Diseases Hospital, National and Kapodistrian University of Athens, 11527 Athens, Greece.
  • Cardiovascular Division, Harvard Medical School, Brigham and Women's Hospital, Boston, MA 02115, USA.

ORCID-Profile: Sotirios Pililis, Stamatios Lampsas, Aikaterini Kountouri, John Thymis, Loukia Pliouta, Melpomeni Peppa, Evangelos Oikonomou, Ignatios Ikonomidis

Zitieren

APA

Lambadiari, V., Pililis, S., Lampsas, S., Kountouri, A., Thymis, J., Pliouta, L., Peppa, M., Kalantaridou, S., Oikonomou, E., Siasos, G., & Ikonomidis, I. (2025). Endothelial Function and Matrix Metalloproteinase 9 (MMP9) in Women with Polycystic Ovary Syndrome (PCOS). International Journal of Molecular Sciences. https://doi.org/10.3390/ijms26125488

Vancouver

Lambadiari V, Pililis S, Lampsas S, Kountouri A, Thymis J, Pliouta L, et al. Endothelial Function and Matrix Metalloproteinase 9 (MMP9) in Women with Polycystic Ovary Syndrome (PCOS). International Journal of Molecular Sciences. 2025. doi:10.3390/ijms26125488

BibTeX
@article{Lambadiari2025,
  author = {Lambadiari, Vaia and Pililis, Sotirios and Lampsas, Stamatios and Kountouri, Aikaterini and Thymis, John and Pliouta, Loukia and Peppa, Melpomeni and Kalantaridou, Sophia and Oikonomou, Evangelos and Siasos, Gerasimos and Ikonomidis, Ignatios},
  title = {Endothelial Function and Matrix Metalloproteinase 9 (MMP9) in Women with Polycystic Ovary Syndrome (PCOS)},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms26125488}
}
Kostenlos starten →